Ge Healthcare Technologies INC Form 4 insider transactions

Kevin Michael O'Neill, CEO of PDx at GE HealthCare Technologies Inc., reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., reported disposing of shares to cover tax withholding obligations related to vesting restricted stock units.

Roland Rott, CEO of Imaging at GE HealthCare Technologies Inc., exercised employee stock options and sold a portion of the acquired shares to cover the exercise price and tax obligations.

Philip Rackliffe, CEO of AVS at GE HealthCare Technologies Inc., sold 900 shares of common stock on November 5, 2024.

Kenneth R. Stacherski, Chief Supply Chain & Service Officer of GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.

Philip Rackliffe, CEO of Ultrasound & IGT at GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.

Roland Rott, CEO of Imaging at GE HealthCare Technologies Inc., reports the withholding of 685 shares to cover tax obligations related to vesting restricted stock units on September 1, 2024.

James Saccaro, CFO of GE HealthCare Technologies Inc., sold 1,740 shares of common stock on September 1, 2024, to cover tax obligations related to vesting restricted stock units.

Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., reports the withholding of 458 shares to cover tax obligations related to vesting restricted stock units.

Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., sold shares to cover tax obligations related to vesting restricted stock units.

Frank R. Jimenez, GC & Corporate Secretary of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Peter J. Arduini, President and CEO of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Director Culp H Lawrence Jr. of GE HealthCare Technologies Inc. reports disposition of shares to cover tax obligations.

Chief People Officer Adam Holton reports the acquisition of restricted stock and stock options in GE HealthCare Technologies Inc.

Roland Rott, CEO, Imaging, of GE HealthCare Technologies Inc., reports the acquisition of restricted stock units and employee stock options.

Philip Rackliffe, CEO of Ultrasound & IGT at GE HealthCare Technologies Inc., reports the acquisition of restricted stock units and an employee stock option.

Kenneth R. Stacherski, Ch. Supply Chain & Serv. Ofc. of GE HealthCare Technologies Inc., sold 19,008 shares of common stock at a price of $83.22 per share on August 14, 2024.

Thomas Westrick, CEO of Patient Care Solutions at GE HealthCare Technologies Inc., sold 2,750 shares of common stock at an average price of $80.78 on August 7, 2024.

CEO of Imaging at GE HealthCare Technologies, Roland Rott, reports disposition of shares to cover tax obligations related to vesting of restricted stock units.

Kevin Michael O'Neill, CEO, PDx of GE HealthCare Technologies Inc., reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Chief Financial Officer of GE HealthCare Technologies Inc., James Saccaro, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.

Taha Kass-Hout, Chief Technology Officer of GE HealthCare Technologies Inc., sold 3,300 shares of common stock at an average price of $78.70 on May 28, 2024.

Director Phoebe L. Yang Watkin acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.

Director William J. Stromberg acquired shares of GE HealthCare Technologies Inc. through restricted stock units and deferred stock units.

Director Tomislav Mihaljevic reports acquisition of 2,440 shares of GE HealthCare Technologies Inc. common stock through restricted stock units.

Director Anne T. Madden reports the acquisition of restricted stock units and deferred stock units in GE HealthCare Technologies Inc.

Director Catherine A. Lesjak acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.

Director Risa J. Lavizzo-Mourey acquired 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.

Director Howell Lloyd Jr. reports the acquisition of 2,440 restricted stock units of GE HealthCare Technologies Inc. on May 21, 2024.

Director Rodney F. Hochman acquired shares of GE HealthCare Technologies Inc. through restricted stock units and deferred stock units.